MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, IRON had -$101,285K decrease in cash & cash equivalents over the period. -$181,326K in free cash flow.

Cash Flow Overview

Change in Cash
-$101,285K
Free Cash flow
-$181,326K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Maturities of marketable securit...
    • Proceeds from sale of common sto...
    • Stock-based compensation
    • Others
Negative Cash Flow Breakdown
    • Purchases of marketable securiti...
    • Net loss
    • Prepaid expenses and other curre...
    • Others

Cash Flow
2025-12-31
Net loss
-212,184
Depreciation and amortization
281
Stock-based compensation
34,340
Amortization/accretion of investment securities
8,519
Loss from initial consolidation of variable interest entity
-852
Non-cash lease expense
473
Non-cash interest expense
837
Other non-cash items
-1
Prepaid expenses and other current assets
8,922
Accounts payable
1,070
Accrued external research and development expenses
4,310
Other accrued expenses
6,882
Operating lease liabilities
186
Net cash used in operating activities
-180,393
Purchases of marketable securities
849,585
Maturities of marketable securities
456,219
Purchases of property and equipment
933
Net cash used in investing activities
-394,299
Proceeds from sale of common stock in underwritten offerings, net of issuance costs paid
440,346
Proceeds from sale of pre-funded warrants in underwritten offerings, net of issuance costs paid
14,076
Proceeds from sale of common stock in at-the-market offerings, net of issuance costs paid
9,766
Proceeds from issuance of long-term debt, net of issuance costs paid
0
Payment of debt issuance costs
0
Proceeds from stock option exercises
8,641
Contributions from employee stock purchase plan
578
Net cash provided by financing activities
473,407
Net (decrease) increase in cash, cash equivalents and restricted cash
-101,285
Cash, cash equivalents and restricted cash, beginning of period
192,672
Cash, cash equivalents and restricted cash, end of period
91,387
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from sale ofcommon stock in...$440,346K Proceeds from sale ofpre-funded warrants in...$14,076K Proceeds from sale ofcommon stock in...$9,766K Proceeds from stockoption exercises$8,641K Contributions from employeestock purchase plan$578K Net cash provided byfinancing activities$473,407K Net (decrease)increase in cash, cash...-$101,285K Canceled cashflow$473,407K Maturities of marketablesecurities$456,219K Stock-based compensation$34,340K Other accruedexpenses$6,882K Accrued externalresearch and development...$4,310K Accounts payable$1,070K Loss from initialconsolidation of variable...-$852K Non-cash interestexpense$837K Non-cash lease expense$473K Depreciation andamortization$281K Operating leaseliabilities$186K Other non-cash items-$1K Net cash used ininvesting activities-$394,299K Canceled cashflow$456,219K Net cash used inoperating activities-$180,393K Canceled cashflow$49,232K Purchases of marketablesecurities$849,585K Purchases of property andequipment$933K Net loss-$212,184K Prepaid expenses andother current assets$8,922K Amortization/accretion of investmentsecurities$8,519K

Disc Medicine, Inc. (IRON)

Disc Medicine, Inc. (IRON)